The Role and Importance of Clinical Trial Registries and Results Databases

Principles and Practice of Clinical Research

Volumn , Issue , 2012, Pages 171-181

  Tse, Tony ^a   Zarin, Deborah A ^a   Williams, Rebecca J ^a   Ide, Nicholas C ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84884466709     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-382167-6.00015-1     Document Type: Chapter

References (40)

1. Zarin D.A., Tse T. Medicine. Moving toward transparency of clinical trials. Science 2008, 319:1340-1342.
2. Simes R.J. Publication bias: the case for an international registry of clinical trials. J Clin Oncol 1986, 4:1529-1541.
3. Emanuel E.J., Wendler D., Grady C. What makes clinical research ethical?. JAMA 2000, 283. 2701-211.
4. Levin L.A., Palmer J.G. Institutional review boards should require clinical trial registration. Arch Intern Med 2007, 167:1576-1580.
5. Mann H. Research ethics committees and public dissemination of clinical trial results. Lancet 2002, 360:406-408.
6. WMA Declaration of Helsinki-Ethical Principles for Medical Research Involving Human Subjects October 2008, World Medical Association, 59th WMA General Assembly, Seoul, Korea.
7. Health Omnibus Programs Extension Act of 1988. Public Law 100-607.
8. Katz D.G., Dutcher G.A., Toigo T.A., Bates R., Temple F., Cadden C.G. The AIDS Clinical Trials Information Service (ACTIS): a decade of providing clinical trials information. Public Health Rep 2002, 117:123-130.
9. Grama L.M., Beckwith M., Bittinger W., Blais D., Lollar C., Middleswarth A., et al. The role of user input in shaping online information from the National Cancer Institute. J Med Internet Res 2005, 7:e25.
10. Food and Drug Administration Modernization Act of 1997. Public Law 105-115.
11. De Angelis C., Drazen J.M., Frizelle F.A., Haug C., Hoey J., Horton R., et al. Clinical trial registration: a statement from the International Committee of Medical Journal Editors. Ann Intern Med 2004, 141:477-478.
12. Laine C., De Angelis C., Delamothe T., Drazen J.M., Frizelle F.A., Haug C., et al. Clinical trial registration: looking back and moving ahead. Ann Intern Med 2007, 147:275-277.
13. An Act Regarding Advertising by Drug Manufacturers and Disclosure of Clinical Trials. Maine State Law, 22 MRSA c605, §2700-A 2005.
14. Rennie D. Trial registration: a great idea switches from ignored to irresistible. JAMA 2004, 292:1359-1362.
15. Food and Drug Administration Amendments Act of 2007. Public Law 110-85.
16. Ghersi D., Pang T. From Mexico to Mali: four years in the history of clinical trial registration. J Evidence-Based Med 2009, 2:1-7.
17. World Health Organization Trial Registration Data Set (Version 1.2.1) 2011, Available at. http://www.who.int/ictrp/network/trds/en/index.html.
18. World Health Organization International Clinical Trials Registry Platform (ICTRP): About the ICTRP Search Portal 2011, Available at. http://www.who.int/ictrp/search/en/.
19. Zarin D.A., Ide N.C., Tse T., Harlan W.R., West J.C., Lindberg D.A. Issues in the registration of clinical trials. JAMA 2007, 297:2112-2120.
20. Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. Official Journal of the European Communities L 2001, 121:34-44.
21. Communication from the Commission regarding the guideline on the data fields contained in the clinical trials database provided for in Article 11 of Directive 2001/20/EC to be included in the database on medicinal products provided for in Article 57 of Regulation (EC) No. 726/2004. Official Journal of the European Union 2008, C168:2.
22. Communication from the Commission-Guidance on the information concerning paediatric clinical trials to be entered into the EU Database on Clinical Trials (EudraCT) and on the information to be made public by the European Medicines Agency (EMEA), in accordance with Article 41 of Regulation (EC) No. 1901/2006. Official Journal of the European Union 2009, C 28:4.
23. Zarin D.A., Keselman A. Registering a clinical trial in ClinicalTrials.gov. Chest 2007, 131:909-912.
24. Tse T., Williams R.J., Zarin D.A. Update on Registration of Clinical Trials in ClinicalTrials.gov. Chest 2009, 136:304-305.
25. National Library of Medicine. Protocol Data Element Definitions (DRAFT), 2010. http://ClinicalTrials.gov.
26. Tse T., Williams R.J., Zarin D.A. Reporting "basic results" in ClinicalTrials.gov. Chest 2009, 136:295-303.
27. Schulz K.F., Altman D.G., Moher D. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med 2010, 152:726-732.
28. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline E3: Structure and Content of Study Reports, Nov 1995. ICH. November 30, 1995.
29. Zarin D.A., Tse T., Williams R.J., Califf R.M., Ide N.C. The ClinicalTrials.gov results database-update and key issues. N Engl J Med 2011, 364:852-860.
30. Glickman S.W., McHutchison J.G., Peterson E.D., Cairns C.B., Harrington R.A., Califf R.M., et al. Ethical and scientific implications of the globalization of clinical research. N Engl J Med 2009, 360:816-823.
31. Ross J.S., Mulvey G.K., Hines E.M., Nissen S.E., Krumholz H.M. Trial publication after registration in ClinicalTrials.gov: a cross-sectional analysis. PLoS Med 2009, 6. e1000144.
32. Mathieu S., Boutron I., Moher D., Altman D.G., Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 2009, 302:977-984.
33. Ide N.C., Loane R.F., Demner-Fushman D. Essie: a concept-based search engine for structured biomedical text. J Am Med Inform Assoc 2007, 14:253-263.
34. Improving the Public Interface for Use of Aggregate Data in. Clinical Trials Transformation Initiative. (Available at); 2011. https://www.trialstransformation.org/projects/improving-the-public-inter face-for-use-of-aggregate-data-in-clinicaltrials.gov/.
35. Turner E.H., Matthews A.M., Linardatos E., Tell R.A., Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med 2008, 358:252-260.
36. Editorial Is GSK guilty of fraud?. Lancet 2004, 363:1919.
37. Juni P., Rutjes A.W., Dieppe P.A. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?. BMJ 2002, 324:1287-1288.
38. Krumholz H.M., Ross J.S., Presler A.H., Egilman D.S. What have we learnt from Vioxx?. BMJ 2007, 334:120-123.
39. Mitka M. Controversies surround heart drug study: questions about Vytorin and trial sponsors' conduct. JAMA 2008, 299:885-887.
40. Vedula S.S., Bero L., Scherer R.W., Dickersin K. Outcome reporting in industry-sponsored trials of gabapentin for off-label use. N Engl J Med 2009, 361:1963-1971.